Riptide Antimicrobial Research Highlighted on Defense Department Website
July 3, 2018
SAN FRANCISCO, CA. – Riptide’s research supported by the US Department of Defense Medical Research and Development Program (DMRDP) today became the featured program on the Congressionally Directed Medical Research Programs (CDMRP) website. CDMRP cites examples of outstanding research on its website and in the CDMRP Annual Report.
A summary of this Riptide research is available on the CDMRP site at http://cdmrp.army.mil/dmrdp/research_highlights/18clemens_highlight.
In addition, the Riptide research is now one of two programs cited as 2018 Research Highlights of the Military Infectious Diseases Research Program (JPC-2). The annual Research Highlights are viewable online at http://cdmrp.army.mil/dmrdp/jpc2highlights.
Dr. L. Edward Clemens, Principal Investigator, commented, “We’re proud of these distinctions and of the regard DoD experts have accorded this program. We expect to build on the promising results of this research, to bring necessary anti-infective solutions to the challenging combat environment.”
Riptide Bioscience, Inc., with laboratories in Vallejo, California, maintains an intensive program of research into peptide-based therapeutics. Contact: email@example.com